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Abstract 
Metabolic syndrome is a condition in which the components – central adiposity, insulin 
resistance, atherogenic dyslipidemia, and elevated blood pressure - confer increased 
cardiovascular morbidity and mortality.  A pilot clinical practice improvement project was 
developed and implemented using shared medical appointments to address cardiovascular 
disease risk in adult patients at a rural health care clinic on the southern Kenai Peninsula, Alaska 
who met the diagnostic criteria for metabolic syndrome.  Statistically significant improvement in 
self-reported minutes of exercise was demonstrated for the nominal group of participants.  
Participants were at least as satisfied or more satisfied with shared medical appointments 
compared to traditional medical appointments.  Limitations aside, the Doctor of Nursing Practice 
(DNP) project demonstrated the feasibility of using shared medical appointments to address 
cardiovascular disease risk in this patient population.  There is need for additional research into 
the “physiology,” or curricular and other structural and procedural elements of shared medical 
appointments for patients with metabolic syndrome that would afford decreased cardiovascular 
disease risk.  The Doctor of Nursing Practice (DNP) project goals were in accordance with the 
overarching aims of the National Quality Strategy that build on the Institute for Healthcare 
Improvement’s Triple Aim – cost-effective, patient-centered, quality care that improves health.  
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 Nomenclature 
n designates the number of members of sample or population 
p designates probability value 
Z  designates standard score 
AAFP American Academy of Family Physicians 
AACN American Association of Colleges of Nursing 
ACSM American College of Sports Medicine 
ApoB Apolipoprotein B 
ACC American College of Cardiology 
ADA American Diabetes Association 
AHA American Heart Association 
AHRQ Agency for Healthcare Research and Quality 
AMA American Medical Association 
BMI body mass index 
CHD coronary heart disease 
CMA certified medical assistant 
CMS Centers for Medicare and Medicaid Services 
CVD cardiovascular disease 
DM diabetes mellitus, or diabetes 
DNP Doctor of Nursing Practice 
E&M evaluation and management 
EHR electronic health record 
EIM Exercise is Medicine 
FPG fasting plasma glucose 
HDL-C high density lipoprotein-cholesterol 
HIPAA Health Insurance Portability and Accountability Act 
HMC Homer Medical Center 
HTN hypertension 
IDF International Diabetes Federation 
IRB Institutional Review BoardJBS Joint British Society 
LDL-C low density lipoprotein-cholesterol 
MetS metabolic syndrome 
NHANES National Health and Nutrition Examination Survey 
non-HDL-C non-high density lipoprotein cholesterol (Total cholesterol – HDL-C) 
NQS National Quality Strategy 
PCNA Preventive Cardiovascular Nurses Association 
PPRNet Primary (Care) Practices Research Network 
PSMA physicals shared medical appointment 
SMA shared medical appointment 
SON School of Nursing 
SPH  South Peninsula Hospital 
QCDR Qualified Clinical Data Registry 
UAA University of Alaska Anchorage 
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Overview of the Problem 
Metabolic syndrome is a condition in which the components – central adiposity, insulin 
resistance, atherogenic dyslipidemia, and elevated blood pressure - confer increased 
cardiovascular morbidity and mortality.  Identifying patients with metabolic syndrome doubles 
the prediction of cardiovascular disease, and because the components can be reversed, 
recognition then facilitates an effective treatment approach (Han & Lean, 2015) that is well-
suited for management by the primary care clinician.  The purpose of this Doctor of Nursing 
Practice (DNP) project was to develop and implement a pilot clinical quality improvement 
program using shared medical appointments to address cardiovascular disease risk in adult 
patients at a rural health care clinic on the southern Kenai Peninsula, Alaska, who met the 
diagnostic criteria for metabolic syndrome.  
Background 
Endocrine and biochemical abnormalities seen in metabolic syndrome include glucose 
intolerance, insulin resistance, hypercortisolism, hypertriglyceridemia, reduced HDL cholesterol 
(HDL-C), and raised small dense LDL cholesterol (LDL-C).  Overt pathophysiological 
conditions include type 2 diabetes, coronary heart disease, polycystic ovarian syndrome, obesity, 
hypertension, stress, depression, and non-alcoholic steatohepatitis (NASH) (Han & Lean, 2015).  
Metabolic syndrome includes complex disease processes, but the core metabolic abnormality is 
considered to be insulin resistance (Han & Lean, 2015; Eckel, Alberti, Grundy & Zimmett, 
2010).  Patel et al. (2014) provided an understandable synopsis of the pathogenesis of metabolic 
syndrome in their article, Metabolic Syndrome and its Impact on Cardiovascular Disease, 
printed in a 2014 issue of the Journal of Metabolic Syndrome.  
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In clinical practice, obesity is the widely recognized phenotype, but it is unclear if obesity 
is a cause or consequence of metabolic syndrome (Falkner & Cossrow, 2014).  Han and Lean 
(2015) have suggested that the cluster of factors that define metabolic syndrome are revealed by 
weight gain and age.  Genetic and environmental factors play a part in metabolic syndrome; 
besides genetic mutations that have been associated with metabolic syndrome, it is recognized 
that such environmental factors as a Westernized lifestyle that is high in dietary fat and physical 
inactivity are contributive (Han & Lean, 2015).  Regardless of whether obesity is causative or the 
result of metabolic syndrome, interventions focused on weight loss through diet, exercise, and/or 
pharmacologic means can effectively reduce cardiovascular disease risk. 
Clinical Significance  
The International Diabetes Federation has suggested that metabolic syndrome is driving 
the global epidemics of type 2 diabetes and cardiovascular disease.  IDF prevalence estimates 
suggest 20-25% of the world’s population is affected, and that affected persons are twice as 
likely to die from a heart attack or stroke and three times as likely to have a heart attack or stroke 
compared to persons without metabolic syndrome (IDF, n.d.).  National Health and Nutritional 
Examination Survey (NHANES) data from 2003-2012 estimated the overall prevalence of 
metabolic syndrome in the United States was 33%, compared to 34% between 1999-2006 
(Aguilar, Bhuket, Torres, Liu, & Wong, 2015).  Aguilar et al. (2015) have suggested that greater 
awareness of metabolic syndrome and its health consequences may be responsible for 
improvements in optimization of treatment of metabolic syndrome components that have 
resulted in stability instead of worsening of prevalence in the United States in recent years.  Even 
still, prevalence estimates suggest the need for additional intervention. 
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Current Clinical Family Practice 
At the South Peninsula Hospital-owned Homer Medical Center outpatient clinic there are 
few patients whose problem list includes a diagnosis of metabolic syndrome, yet there are many 
who meet the diagnostic criteria for metabolic syndrome.  Formal recognition and diagnosis 
make metabolic syndrome amenable to intervention and resultant health improvement (Han & 
Lean, 2015).  Clinical inquiry may be defined as “a process in which clinicians gather data 
together using narrowly defined clinical parameters to appraise the available choices of treatment 
for the purpose of finding the most appropriate choice of action” (Horowitz, Singer, Makuch, & 
Viscoli, 1996, as cited in Melnyk & Fineout-Overholt, 2015, p. 27).  Formulating a clinical 
question in a structured way, such as in a PICOT format, for example, can direct evidence-based 
practice.  
PICOT Question  
PICOT is an acronym for the components of a clinical question: patient population (P), 
intervention (I), comparison intervention or issue of interest (C), outcome (O), and timeframe, or 
time that it takes for the intervention to achieve the outcome (T) (Stillwell, Fineout-Overholt, 
Melnyk, & Williamson, 2010).  The PICOT question for this project inquiry follows:  In adult 
patients at Homer Medical Center who met the diagnostic criteria for metabolic syndrome (P), do 
shared medical appointments (I) carried out over the course of six weeks (T), decrease 
cardiovascular disease risk (O)?   A comparison (C) was not indicated for this project inquiry. 
 Population (P).  Adult patients at Homer Medical Center who met diagnostic criteria for 
metabolic syndrome were identified as the population of interest.  The criteria that were used for 
diagnosis are those outlined in the paper, Joint Scientific Statement of the International Diabetes 
Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood 
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Institute: American Heart Association: World Heart Federation: International Atherosclerosis 
Society; and International Association for the Study of Obesity (Alberti et al., 2009).  This 
definition for clinical diagnosis of metabolic syndrome specifies three of the following five 
criteria: elevated waist circumference (population- and country-specific definitions, but for these 
purposes defined as >94 cm male, >80 cm female); elevated triglycerides greater than 150 
mg/dL, or history of treatment for same; reduced HDL-cholesterol (C) less than 40 mg/dL male 
or less than 50 mg/dL female, or history of treatment for reduced HDL-C; elevated blood 
pressure greater than 130/85 mm Hg or treatment for previously diagnosed hypertension; and 
elevated fasting glucose greater than 100 mg/dL or drug treatment for elevated glucose (Alberti 
et al., 2009).  According to this definition, abdominal obesity is not a prerequisite for a diagnosis 
of metabolic syndrome as it is according to the International Diabetes Federation.  When body 
mass index is greater than 30 kg/m2, Han and Lean (2015) have suggested that one may assume 
waist circumference is above the treatment level.  Most patients with diabetes meet these criteria 
for metabolic syndrome (Alberti et al., 2009).  Alberti et al. (2009) nicely summarized the 
various diagnostic criteria for metabolic syndrome that have been suggested over the years by 
different organizations, such as the IDF and American Heart Association/National Heart, Lung 
and Blood Institute.  These criteria for metabolic syndrome were chosen over the more widely 
used and recognized Adult Treatment Panel (ATP) III of the National Cholesterol Education 
Program (NCEP) because they are less exclusive, with criteria that comprise lower cut-offs for 
waist circumference and fasting plasma glucose.  The criteria are directed toward cardiovascular 
disease prevention and diabetes prevention (Han & Lean, 2015).  Note that all of the individual 
components are generally below treatment thresholds, but combined in metabolic syndrome, 
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confer an elevated cardiovascular disease risk.  Metabolic syndrome confers a five-fold increased 
risk for type 2 diabetes (Alberti et al., 2009).   
Intervention (I).  Shared medical appointments took place over the course of six weeks 
and included patient education and counseling, peer support, and individual patient assessment 
and treatment that included lifestyle interventions and pharmacologic therapies as indicated. 
Shared medical appointments or group visits have been shown to be an effective model of care 
that incorporate patient education, foster peer support, and which facilitate health-related 
behaviors (Jessee & Rutledge, 2012; Greer & Hill, 2011).  Greer and Hill (2011) and Mackey 
(2009) noted improved outcomes from group visits with patients who have metabolic syndrome.  
There is evidence-based practice support for the effectiveness of nurse practitioner-led group 
visits for chronic disease (Jessee & Rutledge, 2012).  Group visits, then, are a likely model of 
care for the treatment of patients with metabolic syndrome.  
Comparison (C).  Comparison need not always be included in the development of 
focused foreground clinical questions.  Such was the case with this clinical inquiry.  There were 
no intervention comparisons for this scholarly project.  
Outcomes (O).  The project design included pre- and post-program assessments of 
several health measures including cardiovascular disease risk based on a 10-year cardiovascular 
risk calculator, and biometrics (waist circumference, blood pressure, weight, BMI) as well as 
labs (serum glucose, hemoglobin A1c, and lipids) as other quantitative measures of the efficacy 
of shared medical appointments for patients with metabolic syndrome.  Self-reported minutes of 
exercise per week were correlated with this data.  Satisfaction with shared medical appointments 
was assessed post-program using a five-point Likert scale.  
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Timeframe (T).  The timeframe for implementation of this pilot program for metabolic 
syndrome shared medical appointments took place over the course of six weeks, from July 11, 
2016, to August 15, 2016.  Post-program comparison outcomes data were collected 
approximately ten weeks after the last shared medical appointment.   
Conclusion 
The prevalence of metabolic syndrome suggests the need for intervention to decrease the 
inherent cardiovascular disease burden.  It is both a responsibility and a challenge for health care 
providers to develop effective models of care in order to improve quality of life and reduce 
disease burden (Ridge, 2012).  Shared medical appointments are purported to include what are 
considered to be key components of health care – regular medical care, self-management 
education, and support (Ridge, 2012).
 Review of the Literature 
A plethora of information about metabolic syndrome exists in the literature.  This has 
accelerated in parabolic fashion through the years from 1920 when Swedish physician Eskil 
Kylin noted the association of hypertension, hyperglycemia, obesity, and hyperuricemia 
(Nilsson, 2001), till Gerald Reaven’s Banting Lecture noting the medical diagnosis termed 
“Syndrome X” in 1988 and recognition that the constellation of symptoms confers multiplicative 
cardiovascular disease risk (Reaven, 1988), up until most recent research into genetic 
underpinnings of metabolic syndrome (O’Neill & O’Driscoll, 2014).  Although several 
organizations provide different definitions of metabolic syndrome, their criteria are not 
dissimilar, so this does not take away from the importance of focusing on recognition and 
treatment to reduce inherent cardiovascular disease risk.  Some researchers suggest that, since it 
is not a disease but a syndrome, and this relationship may be influenced by other factors not 
included in current definitions such as age, sex, low density lipoprotein cholesterol (LDL-C), 
tobacco use, etc., health care providers must pay attention to any components in the definition of 
metabolic syndrome, even if the patient doesn’t meet all diagnostic criteria for a diagnosis of 
metabolic syndrome (Kassi, Pervanidou, Kaltsas, & Chrousos, 2011; Ma & Zhu, 2013).  Neither 
does any debate or controversy regarding whether or not the components of the syndrome, or the 
syndrome as a whole, better predicts cardiovascular disease risk take away from the important 
interventions to be made in this population.  The literature is consistent in the recommendation 
for lifestyle changes primarily, and medical management secondarily, to prevent, reduce, if not 
reverse, cardiovascular disease (Mujica et al., 2010).  The need to realize effective strategies for 
decreasing the incidence of metabolic syndrome was emphasized in the literature (Dunkley et al., 
2011; Sperling et al., 2015).  Certainly, the potential to positively affect the population of adults 
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with metabolic syndrome is promising, and shared medical appointments or group visits are 
postulated as an effective care delivery method to achieve this end. 
Methodology 
A review of current literature pertaining to metabolic syndrome and shared medical 
appointments or group visits was undertaken. The goal of this search of the literature is in 
accordance with the Institute of Medicine’s aim to use evidence from research “to determine 
effective strategies for implementing system-based change to improve care processes and patient 
outcomes” (Institute of Medicine, 2011, as cited in Melnyk & Fineout-Overholt, 2015, p. 77).  
That there was no lack of information in the literature about the topic of concern created a 
challenge in directing the focus of inquiry on interventions directed to improving clinical 
practice.  
Strategies. Terms used in the structured clinical question in PICOT format guided the 
literature review.  Key words included in the literature search included metabolic syndrome, 
group visits, and shared medical appointments.  A Quicksearch of “any content” of the 
University of Alaska Anchorage Consortium Library using the search term metabolic syndrome 
revealed 425,425 results. Use of the search terms shared medical appointments and group visits 
retrieved 36,166 and 1,018,485 articles, respectively.  Databases that were included to narrow the 
focus of the literature search included the Cochrane Library, Cumulative Index of Nursing and 
Allied Health Literature (CINAHL), PubMed, Medline, Ovid, PsycINFO, and Wiley Online 
Library, and Turning Research into Practice (TRIP).  The initial search for the term metabolic 
syndrome in PubMed yielded 115,320 articles, 112,548 were discovered using TRIP, 131,007 in 
Wiley Online Library, and 71,040 articles in PsycINFO.  In CINAHL, for example, with use of 
subject headings to describe article content, metabolic syndrome was converted to metabolic 
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syndrome x as its search term.  None to very few additional articles were found, depending on 
the database, when older search terms were also used, including Reaven syndrome, Syndrome X, 
dysmetabolic syndrome, and insulin resistance syndrome.  A DynaMed search revealed clinical 
practice guidelines not readily found in the above databases. 
 Expansion of metabolic syndrome, or “explode” in CINAHL and MEDLINE, among 
other databases, identified topics that included epidemiology, etiology, physiopathology, etc., 
and allowed narrowing of the topic as these could be selected or eliminated from the search in a 
focused, step-wise fashion.  Limiters were set within the databases to include evidence-based 
practice results and full-text articles, English language, and adults, among others.  The most 
current information was sought by limiting the search to literature published from 2010 to 
present.  Review of the references in published articles of interest (what is often called a hand 
search of reference lists) also revealed relevant scholarly articles.  
 Other sources of external evidence came from the National Guideline Clearinghouse; the 
National Institutes of Health, National Heart, Lung, land Blood Institute; Preventive 
Cardiovascular Nurses Association (PCNA), American College of Sports Medicine (ACSM), 
and the American Academy of Family Physicians (AAFP).  PCNA has helpful patient 
educational resources on components of metabolic syndrome.  The AAFP, in particular, included 
very practical information about metabolic syndrome group visits that informed the project 
design, including a template for the consent form.  Articles found in the search included the 
following: scholarly review of topic(s), evidence-based synopses, clinical Q&A/inquiry, practice 
interventions, practice guidelines, systematic reviews and meta-analyses, randomized controlled 
trials/clinical trials, prospective cohort study, and comparative studies. 
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Data Evaluation.  Melnyk and Fineout-Overholt (2015) have espoused the idea that 
critical appraisal of evidence is a hallmark of evidence-based practice.  Scholarly articles were 
evaluated in accordance with the critical appraisal criteria of Mathuna and Fineout-Overholt 
(2015).  These criteria involved an examination of validity (whether or not results are well-
founded or true), reliability (how consistently the same construct is measured) and applicability 
of findings (value/worth to my clinical practice).  These criteria are applicable to different types 
of research designs, whether case studies, case-control studies, cohort studies, randomized 
controlled trials, or systematic reviews of the literature.  Inherent in these criteria are an 
assessment of bias, confounding results, effect size, and confidence intervals. 
Findings 
The results of the literature review, although proliferative with respect to metabolic 
syndrome and shared medical appointments or group visits, found only a single article 
addressing metabolic syndrome and shared medical appointments or group visits - that of Greer 
and Hill (2011).  Several papers included discussion of shared medical appointments aimed at 
reducing cardiovascular disease risk (Kirsch et al., 2007; Pastore, Rossi, & Tucker, 2013).  There 
were many articles that support shared medical appointments as a model for improved care in 
chronic disease (Bartley & Haney, 2010; Edelman et al., 2012; Egger et al., 2015: Watts et al., 
2009) including may randomized controlled trials and observational studies which document 
efficacy of this model of care for type 2 diabetes (Cohen et al., 2011; Edelman et al., 2012; Egger 
et al., 2015; Eisenstat, Ulman, Siegel, & Carlson, 2013; Riley, 2013; etc.), as well as for many 
other conditions.  Common to both type 2 diabetes and metabolic syndrome is management of 
commonly-occurring comorbidities that include hypertension, hyperglycemia, and dyslipidemia 
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to reduce cardiovascular disease, so elements of shared medical visits for treatment of type 2 
diabetes are considered applicable to metabolic syndrome.    
 Lifestyle changes, including exercise and weight loss, as treatment for metabolic 
syndrome are supported by an abundance of research (Crist et al., 2012; LeFevre, 2014; Mujica 
et al., 2010).  These support exercise as an important, if not central intervention (Green, Fox, & 
Grandy, 2010).  The American College of Sports Medicine (ACSM) Exercise is Medicine (EIM) 
program provides the means to supporting exercise as an effective intervention for treatment for 
metabolic syndrome (ACSM, 2015; Sperling et al., 2015).  ACSM recommendation for exercise 
of at least 150 minutes per week is an intervention that can benefit all the components of 
metabolic syndrome (e.g., hypertension, dyslipidemia, etc.).  
 The Cardiometabolic Think Tank convened in June 2014 in Washington, D.C. with the 
goal of improving morbidity and mortality among those who have metabolic syndrome or who 
are at risk for metabolic syndrome (Sperling et al., 2015).  The Think Tank scientists suggested 
many principles for implementing a new care model for which shared medical appointments are 
well-suited.  These include treatment with lifestyle changes that focus on exercise, weight loss, 
and nutrition.  Certain strategies were expressly included in their report, including promoting the 
American College of Sports Medicine (ACSM) Exercise is Medicine (EIM) initiative, and 
making physical activity a “vital sign” in the clinic setting.  The Cardiometabolic Think Tank 
participants’ recommendations are concordant with shared medical appointments as a model of 
care delivery.  
Benefits of shared medical appointments are documented in the literature with respect to 
counseling (LeFevre, 2014), education (Sovariova & Hrehova, 2014), and support (Eisenstat et 
al., 2013; Shaya et al., 2014).  So too have they been shown to include effective group 
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interventions for weight loss (Gallagher et al., 2012).  Research suggests shared medical 
appointments can improve outcomes compared to standard primary care practice visits (Bartley 
& Haney, 2010; Cohen et al., 2011; Dontje & Forrest, 2011). 
Limitations 
Limiting search dates for this project inquiry may have excluded some pertinent 
information, however prudent it was to limit the source information.  By excluding a search for 
articles prior to 2010, some significant articles may have been excluded that would have 
contributed to the literature.  Exception was made for several of these, including the article, 
Harmonizing the Metabolic Syndrome: A Joint Interim Statement of the International Diabetes 
Federation Task Force on Epidemiology and Prevention from the National Heart, Lung, and 
Blood Institute, World Heart Federation, International Atherosclerosis Society, and 
International Association for the Study of Obesity, published in 2009 (Alberti et al., 2009). 
Another limitation is that researchers use different definitions of, and diagnostic criteria for, 
metabolic syndrome.  
Prevention and treatment guidelines for the components of metabolic syndrome are the 
standard, rather than any consensus statement for treatment of metabolic syndrome, per se.  For 
example, Prevention of Type 2 Diabetes Evidence-Based Nutrition Practice Guideline resulted 
from a search of terms in treatment of metabolic syndrome (Academy of Nutrition and Dietetics, 
2014).  Treatment guidelines for metabolic syndrome defer to treatment of the component parts.  
Treatment of the components of metabolic syndrome was done in accordance with established 
national guidelines, including the 2014 Evidence-Based Guideline for the Management of High 
Blood Pressure in Adults (James et al., 2014), the American Diabetes Association Standards of 
Medical Care in Diabetes -2016 (American Diabetes Association, 2016), and the 2013 ACC/AHA 
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Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk 
in Adults: a Report of the American College of Cardiology/American Heart Association Task 
Force on Practice Guidelines (Stone et al., 2014).  Mid-way through the project, the ADA’s 
2015 Standards of Medical Care in Diabetes were replaced by the Standards of Medical Care in 
Diabetes - 2016 when newly updated and published (American Diabetes Association, 2016). 
Conclusion  
This comprehensive integrated review of the literature evaluated current evidence-based 
information about metabolic syndrome and evidence-based practice to support an intervention 
through shared medical appointments to address cardiovascular disease risk in adult patients at 
Homer Medical Center who met diagnostic criteria for metabolic syndrome.  Findings in the 
literature review support implementation of shared medical appointments as a model of health 
care delivery for metabolic syndrome.  
Consistent with integrating best practice into routine care as is suggested in the Future of 
Nursing report (Institute of Medicine, 2010), treatment of metabolic syndrome in the population 
of interest focused on shared medical appointments as the vehicle for facilitating lifestyle 
changes, with attention to exercise and dietary modification as the key interventions.  Medical 
management of metabolic syndrome components of hypertension, dyslipidemia, and insulin 
resistance adhered to established national guidelines.  The literature review reinforced the 
importance of recognition and treatment of metabolic syndrome in primary care practice, and on 
shared medical appointments as the care delivery method to facilitate reduction in cardiovascular 
disease risk in patients at Homer Medical Center who meet diagnostic criteria for metabolic 
syndrome.  
 Organization Framework  
Patient outcomes and the quality of health care are improved when evidence informs 
clinical practice (Melnyk, Gallagher-Ford, Long, & Fineout-Overholt, 2014).  This is widely 
accepted.  Conceptual models or frameworks serve to guide the design and implementation of 
evidence-based practice change (Graham, Tetroe, and K.T. Theories Research Group, 2007).    
A model that employs these steps to guide implementation and sustainability of evidence-based 
practice change is the Model for Evidence-Based Practice Change. The Model for Evidence-
Based Practice Change was chosen as a framework to guide this nurse practitioner-facilitated, 
tailored intervention using shared medical appointments to address cardiovascular disease risk in 
patients in a primary care clinic who met diagnostic criteria for metabolic syndrome.  The Model 
for Evidence-Based Practice Change was determined to be well-suited for this project in order to 
facilitate the move of evidence into practice. 
Evidence-Based Practice Model 
First published in 1999 as A Model for Change to Evidence-Based Practice (Rosswurm 
& Larrabee, 1999), Rosswurm and Larrabee’s revised Model for Evidence-Based Practice 
Change: integrates principles of QI (Dang et al., 2015); includes research utilization and change 
theory, is well-suited to primary practice settings, and is intuitive and logical (Rempler, 2006).  
Rosswurm and Larrabee’s original model for evidence-based practice progresses through six 
steps: 1) assess the need for change in practice; 2) link the problem with interventions and 
outcomes; 3) synthesize the evidence; 4) design practice change; 5) implement and evaluate 
change in practice; and 6) integrate and maintain change in practice.  These steps are depicted in 
Figure 1 (Rosswurm & Larrabee, 1999), which follows: 
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Rosswurm and Larrabee provided an appropriate framework by which this evidence-based 
practice change project was directed. 
Step 1: Assessment of the need for change.  An interest in disease prevention and health 
promotion by the author is at the heart of the project.  In accordance with a model for evidence-
based practice, the first step in the model determined, from an assessment of the need for change, 
that at Homer Medical Center there were few patients whose problem list included a diagnosis of 
metabolic syndrome but many who were at heightened cardiovascular disease risk as a result of 
metabolic syndrome.  Prevalence estimates of patients at Homer Medical Center who met 
diagnostic criteria for metabolic syndrome were considered to be in accordance with national 
statistics.  The importance of recognition of metabolic syndrome through diagnosis, and through 
treatment to prevent cardiovascular disease, is well-established and was thought to be amenable 
to intervention. 
Step 2: Link the problem with interventions and outcomes.  Once the problem of 
interest was identified, formulation of the PICOT question (Stillwell et al., 2010) directed review 
Figure 1. Schematic depicting Rosswurm and Larrabee’s steps in their model for evidence-
based practice 
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and critique of the literature.  The PICOT question for this project inquiry was noted earlier but 
is restated here: In adult patients at Homer Medical Center who met the diagnostic criteria for 
metabolic syndrome, do shared medical appointments, carried out over the course of six weeks, 
decrease cardiovascular disease risk?    
Step 3: Synthesize the evidence.  Findings from current evidence, which includes 
numerous research articles, evidence-based synopses, and practice guidelines, support an 
intervention through shared medical appointments to improve the cardiovascular disease profile 
of those who met diagnostic criteria for metabolic syndrome.  A plethora of information about 
metabolic syndrome has been written over the past three decades, with different definitions of 
metabolic syndrome established.  Debated is the idea that metabolic syndrome should even be 
labeled as a syndrome since there is inconclusive evidence to indicate metabolic syndrome 
confers a higher cardiovascular disease risk than the risk posed by its individual components 
(Larry, 2013).  With prevalence estimates in the U.S. of 33%, the resultant morbidity and 
mortality are significant.  The need to realize effective strategies for decreasing the incidence of 
metabolic syndrome was emphasized in the literature (Dunkley et al., 2011; Sperling et al., 
2015).  Epidemiological studies show that interventions that include diet and exercise reduce the 
risks related to metabolic syndrome.  Medication management is employed secondarily.  
Treatment recommendations follow those of national guidelines for metabolic syndrome 
component parts.  Research supports shared medical appointments as an effective model of 
health care delivery.  There is evidence-based practice support for the effectiveness of nurse 
practitioner-led shared medical appointments for chronic disease (Jessee & Rutledge, 2012). 
Step 4: Design practice change.  Shared medical appointments were suggested as an 
effective model of care to improve the health of adult patients at Homer Medical Center who met 
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diagnostic criteria for metabolic syndrome.  Lifestyle changes, including weight loss –with 
exercise and dietary modification as foci for intervention –as treatment for metabolic syndrome 
are supported by an abundance of research (Crist et al., 2012; LeFevre, 2014; Mujica, 2010). 
Shared medical appointments took place over the course of six weeks and included patient 
education and counseling, peer support, and individual patient assessment and treatment that 
included lifestyle interventions and pharmacologic therapies as indicated. 
Step 5: Implement and evaluate change in practice.  Support for the project was 
secured by the clinic’s medical director (see Institutional Support Letter, Appendix A).  
Implementation of the program took place during summer 2016.  Post-program comparison 
outcomes data was collected approximately ten weeks following the sixth and final shared 
medical appointment.  The implementation period for this program is as described, with the pilot 
program of shared medical appointments a model of care upon which future shared medical 
appointments may be offered, informed by what was learned during the pilot program.  
Formative evaluation is in keeping with tenets of a quality improvement program; that is, 
changes made to the program as it is being carried out lend themselves to process improvement 
in real time (Stetler et al., 2006, as cited in Holly, 2014, p. 160). 
Step 6: Integrate and maintain change in practice.  The goal of the pilot project was to 
establish a working model of health care delivery that can be used to perpetuate future successful 
intervention in those with metabolic syndrome.  It is expected that shared medical appointments 
for patients with metabolic syndrome may continue into the future as a model of care, informed 
by what was learned during the pilot program, that which is learned in subsequent programs as 
information is built upon this foundation, and through continued appraisal of the literature, for 
which a solid foundation will have been established. 
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Conclusion 
The Model for Evidence-Based Practice Change was chosen as a framework to guide the 
clinical practice improvement project using shared medical to address cardiovascular risk in 
adult patients at Homer Medical Center with metabolic syndrome.  Assessment of the need for 
change in a primary care clinic involved recognition that significant morbidity and mortality is 
associated with metabolic syndrome and that an intervention that involves nurse-practitioner 
facilitated, shared medical appointments has good support in the literature as an effective model 
of health care delivery.  These shared medical appointments include key components of health 
care – regular medical care, education, and support (Ridge, 2012).  Evaluation of some 
components of health care was measured to assess the efficacy of the project in order to inform 
future practice.  
 Project Design 
This evidence-based change project purposed to improve cardiovascular disease risk in 
adult patients with metabolic syndrome through their participation in shared medical visits as a 
health care delivery mode.  The emphasis was disease prevention.  Shared medical visits, defined 
as “a series of individual office visits sequentially attending to each patient’s unique medical 
needs individually, but in a supportive group setting where all can listen, interact, and learn” 
(Stevens, Cole, Binns, Dixon, & Egger, 2014), are considered by many to be more appropriate 
for chronic disease management than a traditional office visit.  Steps four, five, and six of 
Rosswurm and Larrabee’s model for evidence-based practice focus on elements of project 
design, and include: (step 4) design practice change; (step 5) implement and evaluate change in 
practice; and (step 6) integrate and maintain change in practice (Larrabee, 2009, as cited in Dang 
et al., 2015; Rosswurm & Larrabee, 1999).  Project design approval by the clinic’s medical 
director paved the way for Institutional Review Board (IRB) review and approval of the project. 
Institutional Review Board 
An Institutional Review Board (IRB) is a committee established to protect the rights and 
welfare of human research subjects (Selwitz, Epley, & Erickson, 2015).  IRB review is required 
when studies involve research of human subjects (Hicks, 2014).  Federal regulations at 45 CFR 
46.102 define research as “a systematic investigation, including research development, testing 
and evaluation, designed to develop or contribute to generalizable knowledge" (U. S. Department 
of Health & Human Services, 2010, 46.102 para. 4).  This project required IRB review despite 
that it was not research per se, and not meant to contribute to “generalizable” knowledge.  
Exempt, expedited or full designation is at the behest of an IRB committee: The IRB committee 
A METABOLIC SYNDROME CLINICAL PRACTICE IMPROVEMENT PROJECT  30 
determines the level of review that is needed for a project.  The IRB proposal was submitted for 
expedited review following successful proposal defense and later received approval of the same.   
The IRB proposal included: the principal investigator’s assurance statement, rationale for 
the project, statement of research question and hypotheses, summary of research design/approach 
including procedures, methodology and resources utilized, data collection methods and tools, 
subject selection including recruitment methods, statement of potential benefits to participants, 
incentives, costs, risks, participant consent, and plan for data storage and retention.  The required 
Collaborative Institutional Training Initiative (CITI Program) Basic/Refresher Course in Human 
Subjects Research was successfully completed September 2015.  This certificate was submitted 
to the IRB committee along with a letter of support from the participating institution (see 
Institutional Support Letter, Appendix A). 
Potential Risk to Participants 
No more than minimal risk to participants was assumed with this project.  However, 
some risk was inherent with the shared medical appointments/group visits since there was 
potential for breach of confidentiality from participants themselves when health matters were 
discussed in the group setting.  Participants were encouraged not to share protected information 
outside the group, and were made aware that the group facilitator could not guarantee 
confidentiality (Arwood & Panicker, 2014).  Framed another way, patients were encouraged not 
to share others’ stories, but that it was alright to share their own.  Participant/patient health 
information became part of the patient’s electronic medical record at Homer Medical Center and 
has implicit health information protections consistent with privacy practices that are a 
requirement of the Health Insurance Portability and Accountability Act (HIPAA), and which are 
upheld at Homer Medical Center/South Peninsula Hospital. 
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An identified potential harm related to financial burden.  A reasonable expectation about 
costs could be made by the patient in advance as he/she would for a traditional visit, by patient 
discourse with his/her insurance representative and/or in consultation with Homer Medical 
Center nurse practitioner and billing staff.  This information was included in the consent form. 
Shared medical appointments were billed to the patient’s/participant’s health insurance according 
to the standard E&M code (usually 99213 or 99214), depending on the level of complexity of the 
visit.  Documentation in the patient’s electronic health record attested to individual medical 
evaluation and management components of care that are provided in the context of a shared 
medical appointment.   
Another potential harm that could occur as a result of this project related to the 
acquisition of blood for pre- and post-program glucose, hemoglobin A1c, and lipids.  Venous 
blood draws or CLIA-waived fasting glucose and lipids was conducted by a licensed 
phlebotomist and trained certified medical assistants, respectively, by following universal 
precautions.  Lab testing is an established health assessment tool in accordance with surveillance 
of metabolic syndrome components, no different than if the participant was being seen in a 
traditional office visit, and subject to patient consent. 
Participants were reminded during the program and with written consent that their 
participation in all aspects of the program is voluntary, and that alternatively they may choose at 
any time not to participate, or they may receive treatment for metabolic syndrome in a traditional 
medical appointment.  
Potential Benefits to Participants 
Potential advantages to patients as a result of project design and implementation may 
have included: peer support and shared experiences from other patients (Stevens, Cole, Binns, 
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Dixon, & Egger, 2014); increased self-efficacy, and knowledge about metabolic syndrome in a 
shared “learning community” that aims “to support the growth of individual knowledge and 
advance the collective knowledge of the group” (Davis & Vitagliano, 2015, p. 633); increased 
perceived quality of health care as a result of additional time spent with a health care provider 
compared to a traditional office visit; and improved adherence to treatment guidelines (Pastore & 
Tucker, 2013).  These potential benefits from participation were not all directly measured in this 
project. 
Evidence-Based Practice Change Design  
Donabedian’s framework was included to further elucidate the evidence-based practice 
change process.  It expands on step four - practice change - of Rosswurm and Larrabee’s model 
for evidence-based practice.  Donabedian (2003, as cited in Holly, 2010) on page 139, has 
suggested an examination of three key measures - structure, process, and outcomes – that can be 
used in a quality improvement project to determine quality in health care.  Structure refers to the 
environment in which care is provided and the care providers’ qualifications to provide that care.  
Process refers to the way in which health care services are provided.  Donabedian has stated that 
outcomes are the products that result from the interaction of structure and process and reflect the 
effect on the patient and how well the intervention was done. 
Structure.  For this project, structure describes the context in which care was provided. 
Organizational culture sets the stage for successful program implementation.  Support for the 
quality improvement project started with institutional support, which was gained and which is 
evidenced by the letter denoted in Appendix A.  The burden of organizing the shared medical 
appointments, as well as facilitating shared medical appointments and providing physical 
assessments within the larger visit was assumed by the nurse practitioner.  There is evidence in 
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the literature supporting the efficacy of shared medical appointments/group visits facilitated by 
advanced nurse practitioners to improve patient outcomes (Watts et al., 2009).  Brief, 
approximately 5-10 minute physical assessments at the beginning of a shared medical 
appointment as indicated.  It was not necessary to solicit other health care providers to conduct 
some of these brief assessments, but would be if more participants attended a session. 
At each session, certified medical assistants (CMAs) were responsible for assessing vital 
signs and participants’ self-reported total minutes of exercise per week.  Assessment of exercise 
served to reinforce American College of Sports Medicine (ACSM) promotion of Exercise is 
Medicine as a key intervention in the treatment of metabolic syndrome.  Waist circumference and 
labs were assessed at the start of the program and approximately ten weeks after the final session 
was completed.  
Roles and role responsibilities of those of the support team, and interprofessional 
teamwork are important to consider, as well as to foster, in successful project design.  
Information technology staff provided assistance in an electronic medical records search for 
patients who met diagnostic criteria for metabolic syndrome to facilitate recruitment efforts.  
Their assistance in the creation of templates adapted for each shared medical appointment 
facilitated documentation in the electronic medical record.  Billing support staff were important 
collaborators with respect to coding as well as billing.  Receptionists and lab personnel similarly 
collaborated.  An on-site lab at Homer Medical Center facilitated lab testing, including CLIA-
waived point of care testing for lipids, glucose, and hemoglobin A1c.  Additional health care 
professionals included a registered dietician and certified diabetes educator, and registered nurse, 
both from South Peninsula Hospital’s American Diabetes Association (ADA)-recognized 
diabetes education program.  These two dietary services personnel were instrumental in 
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facilitating and assisting with shared medical appointment-related education and counseling.  A 
psychiatric nurse practitioner delivered a presentation on mindful eating that reinforced program 
tenets beyond nutrition and which resonated with all in attendance.   
Process.  As stated, process refers to the way in which health care services are provided. 
Egger et al. (2014, p. 151) suggested that:  
primary care could benefit from a shift to an emphasis on process, as much as an 
increase in knowledge of content relating to chronic disease. Processes include 
self-management education, brief interventions, activity scheduling, motivational 
skills, counselling, health coaching, and behavioral and environmental change. 
This reinforces a broader multidisciplinary approach….An alternative model of 
clinical engagement that is worthy of consideration in this respect is the shared 
medical appointment.  
 
The very processes the authors mentioned are purposed in this quality improvement project. 
Organizational culture sets the stage for successful program implementation (International 
Diabetes Federation, n.d.).  Shared medical visits include several minutes of individual 
assessment, but most of the visit took place in a group setting that included education about 
metabolic syndrome and lifestyle interventions that are effective in reducing cardiovascular and 
other disease risk.  The visits took place in a group setting meant to facilitate patient self-
management and peer interaction.  Lifestyle changes, including exercise and weight loss, as 
treatment for metabolic syndrome are supported by an abundance of research (Crist et al., 2014; 
LeFevre, 2014; Mujica, 2010).  Promotion of these lifestyle changes is an important approach in 
treatment of metabolic syndrome, for which the usual office visit appointment is not well-suited.  
Exercise was promoted as an important, if not central intervention (Green, Fox, & Grandy, 2010) 
for improved health.  The American College of Sports Medicine (ACSM) Exercise is Medicine 
(EIM) program provided the means to supporting exercise as an effective intervention for 
treatment for metabolic syndrome (ACSM, 2015; Sperling et al., 2015).  The ACSM 
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recommendation for exercise of at least 150 minutes per week is an intervention that is of benefit 
for all the components of metabolic syndrome (e.g., hypertension, dyslipidemia, etc.).  
Medical management was in accordance with established national guidelines, including 
the 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults 
(James et al., 2014), the American Diabetes Association’s Standards of Medical Care in Diabetes 
– 2016 (American Diabetes Association, 2016), and the 2013 ACC/AHA Guideline on the 
Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: a 
Report of the American College of Cardiology/American Heart Association Task Force on 
Practice Guidelines (Stone et al., 2014). 
Outcomes.  As previously stated, Donabedian’s outcomes refer to the products that result 
from the interaction of structure and process and which reflect the effect on the patient and how 
well the intervention was done.  The goal-based evaluation of the program was formative in 
nature.  Some points outlining formative evaluation strategies that reflect outcomes include: 
patient satisfaction with a shared medical appointment model of care using a Likert scale, pre- 
and post-program comparison of a 10-year cardiovascular risk score, as well as biometric data 
such as patient waist circumference, weight, pre- and post-program self-reported minutes of 
exercise per week, etc.  Outcomes may also relate to effectiveness of the process learned in 
informing future evidence-based practice projects. 
Challenges 
Challenges are to be anticipated in a quality improvement initiative.  Some of these 
challenges included increased demands on support staff time and responsibilities and staff 
adherence with process change.  Bringing collaborative support personnel “on board” with a 
shared vision for improved health care served to minimize their hesitancy and strengthen their 
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support.  Recruitment of other clinicians to assist in short patient assessments was not necessary 
for this intervention but would be assumed if more patients participated in any one shared 
medical appointment.  In that case, collaborative challenges would be lessened if the patient was 
assigned to his/her preferred or primary care provider.   
Billing for shared medical appointments can be a challenge (Jaber, Braksmajer, & 
Trilling, 2006).  Billing was done according to summary recommendations that suggested that 
these visits be billed as individual office visits using existing CPT codes, 99213-99214 according 
to the level of care provided.  Creation of customized templates helped facilitate electronic health 
record documentation of complexity levels for billing purposes.  
Whereas shared medical appointments presented a potential challenge in maintaining the 
confidentiality of protected health information, since participants often share their health 
concerns and personal information with others in the group, no such breaches of confidentiality 
were known to occur.  HIPAA does not specifically address shared medical appointments (Jaber, 
et al., 2006).  A consent form was utilized, adapted from the American Academy of Family 
Physicians and consent templates from IRBNet, the latter accessed as a function of the 
University of Alaska School of Nursing DNP student project.  Participants were required to 
review and sign the consent before participation, and privacy and protection of health 
information were addressed at each visit.  
Drop-out rates of participants have been cited as a potential challenge.  Longer times 
between group visits are associated with higher attrition, with patient drop-out rates for weekly 
group visits relatively lower (Jaber et al., 2006).  Weekly shared medical appointments were 
conducted.   
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Plan for Project Evaluation 
The goal of this project was to provide an evidence-based program to address 
cardiovascular disease risk in adult patients with metabolic syndrome through their participation 
in shared medical visits as a health care delivery mode.  The emphasis was on disease 
prevention.  No benchmarks were suggested against which project evaluation was measured. 
 Post-program patient satisfaction with the shared medical appointment model of care was 
assessed using a five-point Likert scale.  10-year cardiovascular risk was determined via a risk 
calculator (using HDL-C, systolic blood pressure, etc.) at the outset of the program, and post-
program, as was biometric data such as patient waist circumference, weight, BMI, and labs 
including serum glucose, hemoglobin A1c, and lipids.  Statistical analysis of the data was 
employed.  Pre- and post-program self-reported weekly minutes of exercise was recorded.   
Post-Intervention Plans 
The goal in “piloting” this project was not only to establish that shared medical 
appointments are a health care delivery method that is effective for this patient population.  
Review of the literature suggests shared medical appointments or group visits are an effective 
model of care that incorporates patient education, fosters peer support, and which facilitates 
health-related behaviors (Jessee & Rutledge, 2012; Greer & Hill, 2011).  That much is 
established.  Goals with this pilot project were to assess the effectiveness of a program that 
would effectively utilize this health care delivery method of shared medical appointments to 
decrease cardiovascular risk in patients at Homer Medical Center with metabolic syndrome, to 
determine what is needed to create a sustainable program that would benefit similar cohorts of 
patients, as well as to create a template that can be used to provide quality care for patients with 
other chronic conditions.  
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Conclusion  
The project design provided a systematic framework for implementation and 
sustainability of the evidence-based practice change in order to address cardiovascular disease 
risk in adult patients in a primary care clinic who were diagnosed with metabolic syndrome. 
Project design approval by the clinic’s medical director paved the way for proposal defense 
which, in turn, allowed Institutional Review Board (IRB) approval of the proposed project.  No 
more than minimal risk to participants occurred with this project.  Donabedian’s framework was 
included to further elucidate the evidence-based practice change process.  These components 
expound on the organizational culture that is the structure, shared medical appointments with 
inherent support, education and individualized care as a health care delivery method that is its 
process, and an outline of project outcomes, respectively.  Program goals included successful 
implementation, sustainability, and an understanding of how the process might inform and direct 
future projects.
Implementation Process 
 Donabedian’s framework elucidates the evidence-based practice change process that 
informed this project.  Donabedian (as cited in Holly, 2014) has suggested an examination of 
three key measures – structure, process, and outcomes– that can be used in a quality 
improvement project.  Structure, delineated in chapter four, refers to the environment in which 
care is provided.  Process, the topic of this chapter, refers to the way in which health care 
services are provided (Holly, 2014).  Outcomes are the products that result from the interaction 
of structure and process and reflect the effect on the patient and how well the intervention was 
done (Holly, 2014).  Outcomes will be addressed in chapter six.  The process outlined herein 
relates to implementation of the program of shared medical appointments for a small group of 
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patients who met diagnostic criteria for metabolic syndrome.  These shared medical 
appointments combined a private, individual assessment and treatment by the nurse practitioner, 
with group education and facilitated peer interaction and peer support.  
Implementation 
 Institutional Review Board.  Implementation of the Doctor of Nursing Practice (DNP) 
project was predicated on the University of Alaska Anchorage Institutional Review Board (IRB) 
approval.  An expedited review process was in keeping with reasonable and appropriate 
protections so no more than minimal risk is conferred to participants such as from the collection 
of blood samples by finger-stick or venipuncture, financial burden, or from risks related to 
invasion of privacy and breach of confidentiality from patients participating in shared medical 
appointments.  Modifications to the original IRB proposal emphasized protections with respect 
to potential financial burden from participation in the program.  At the behest of the IRB, the 
original proposal was modified with the addition of a participant recruitment script and revision 
of the invitation and consent forms.  Notice of final IRB approval is included in Appendix B. 
 Intervention team.  Early on in the project came backing by the medical director of 
Homer Medical Center.  A letter supporting implementation of the project was received from the 
clinic’s medical director (Appendix A).  The nurse practitioner served as team leader and was 
responsible for medical management.  The supportive clinic staff, including certified medical 
assistant(s), biller/coder, receptionist, phlebotomist, information technology personnel, 
psychiatric nurse practitioner, and the business department director, among others, remained a 
positive factor that facilitated project implementation.  In addition, South Peninsula Hospital 
(SPH) Chief Executive Officer approved utilization of nutrition services personnel for Homer 
Medical Center programs.  This intervention removed a potential institutional barrier and 
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facilitated patient education by a registered dietician regarding patient dietary education and 
dietary modifications that are a cornerstone of treatment of metabolic syndrome.  Contributing 
hospital and clinic staff were able to flex their regular work schedules to facilitate shared medical 
appointments that took place after normal business hours.  Limited clinic space dictated that 
shared medical appointments were conducted after regular business hours.  Limited clinic space 
also necessitated small group size. 
 Participant recruitment.  Adult patients who met the metabolic syndrome criteria were 
personally invited to participate in the shared medical appointments by a primary care provider 
during a clinic visit.  Noffsinger (2009) described this as the single most effective means of 
getting patients to attend shared medical appointments.  Invitation flyers had been placed in the 
patient rooms (Appendix C) and a recruitment script (Appendix ) had been written for clinic staff 
with talking points for the purpose of recruitment.  The small convenience sample numbered 
seven participants.  A sufficient minimal number of participants was obtained in this way, 
without the need to contact patients identified through a search of the electronic health record for 
patients who met IDF criteria.  Implementation and evaluation of just such a pilot test is 
recommended before moving to larger-scale implementation (Hockenberry, Brown, & Rodgers, 
2015; Noffsinger, 2009).   
 Shared medical appointments.  The shared medical appointments for this cohort of 
patients with metabolic syndrome were a subset of the shared medical appointments that 
Noffsinger (2009) has referred to as Physicals SMA (PSMA) because they included a private, 
brief, several-minutes-long individual patient assessments, and treatment (when indicated) by the 
facilitating nurse practitioner/team leader, with the customary group education and facilitated 
peer interaction and peer support.  These PSMAs were heretofore referred to simply as shared 
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medical appointments and will continue to be referred to as shared medical appointments, but 
consideration is given to this physical exam component.  Physical assessment other than an 
assessment of biometric data was not by necessity carried out at each week’s shared medical 
appointment, but each patient had one or more physical assessments in the course of the program 
that were deemed medically necessary.  The SMAs were carried out weekly over a period of six 
weeks between 7/11/16 and 8/15/16.  Class duration was 90 minutes.  
 Consent.  Patient participation was predicated on informed consent (Appendix B 
IRB Approval Letter 
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Appendix C 
Invitation Flyer 
 Appendix D 
Talking Points 
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Appendix  This consent form was read and reviewed with participants and signed before the 
program commenced.  At the start of each weekly shared medical appointment, participants were 
reminded of their agreement to respect the privacy of everyone in the group and to hold 
confidential this health information; participants were discouraged from sharing other 
participants’ “stories” outside of the SMA.  
 Metrics.  Certain measures were obtained from each participant at the beginning of the 
program.  These included fasting glucose and lipid panel, hemoglobin A1c, blood pressure, 
height, weight, body mass index (BMI), waist circumference, and exercise habits.  End-program 
measures were assessed approximately ten weeks after the completion of the sixth and last 
shared medical appointment.  Exercise habits were assessed at each appointment, and 
documented with other “vital signs” in the electronic health record according to activity in 
minutes per day and days per week.  This was meant to reinforce the American College of Sports 
Medicine’s Exercise is Medicine (EIM) initiative as a key intervention in the treatment of 
components of metabolic syndrome (American College of Sports Medicine, 2016).  Coleman et 
al. (2012) established the validity of an exercise “vital sign” in the patient electronic health 
record.  
 Calculation of 10-year risk of cardiovascular disease was determined for each participant 
according to the Joint British Society (JBS)3 risk calculator as was the custom in the clinic, in 
order to communicate risk of endpoints that include coronary heart disease death, nonfatal 
myocardial infarction (MI), transient ischemic attack (TIA), and cerebrovascular accident 
(CVA), among others, as well as the risk reduction that can be realized with lifestyle changes 
(Joint British Societies for the Prevention of Cardiovascular Disease, n.d.;  Wilson, 2016).  The 
JBS3 multivariate risk assessment tool incorporated patient prediction variables including age, 
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gender, ethnicity, height, weight, total cholesterol and triglycerides, and blood pressure, as well 
as patient history of smoking status, whether or not the patient is taking blood pressure 
medication(s), among other health information (Joint British Societies for the Prevention of 
Cardiovascular Disease, n.d.; JBS3 Board, 2014; Wilson, 2016).  Each patient’s 10-year 
cardiovascular disease risk was calculated near the start of the program and approximately ten 
weeks after the last shared medical appointment, using data from the post-program lab draw.  For 
most participants, a handout summarizing their personal risk criteria for a diagnosis of metabolic 
syndrome was provided and reviewed during that second shared medical appointment, as were 
lab results, and 10-year cardiovascular disease risk according to JBS3.  Risk assessment 
equations, including JBS3, inform decision-making and provide guidelines regarding statin use 
(Stone et al., 2014).  
 Educational curricula.  For this cohort with metabolic syndrome, the educational 
curriculum focused on providing an understanding of metabolic syndrome and its implications, 
disease prevention and health promotion strategies that included dietary modification and 
exercise to achieve and maintain a healthy body weight and body fat distribution, and personal 
empowerment to achieve behavior change.  Curricular elements were therefore logically 
consistent with that of Dunkley et al. (2011) in The Reversal Intervention for Metabolic 
Syndrome (TRIMS) study.  The content was also adopted from Metabolic Syndrome: From Risk 
Factors to Management (Blaha & Tota-Maharaz, 2012).  Curricular elements are outlined below: 
 Metabolic syndrome – Diagnostic criteria; pathophysiology (simplified) including insulin 
resistance and resultant hyperinsulinemia, abdominal obesity, atherogenic dyslipidemia, 
subclinical inflammation, etc., and consequences including increased cardiovascular 
disease risk and risk of type 2 diabetes, hypertension, etc.; interventions to prevent, 
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reduce or reverse effects; fluidity of metabolic syndrome in terms of its variable effects; 
and comorbidities (depression, smoking, etc.). 
 Physical activity – Benefits of exercise, recommendations for exercise, barriers and 
facilitators, the role of physical activity in weight loss.  Exercise is Medicine tenets were 
championed.  
 Nutrition – Food and energy balance, food groups, food messages (media, family), 
making healthier food choices, recipe ingredient substitution, diets implicated in 
reversing metabolic syndrome, the role of nutritional choices in weight loss.  
 Self-management – Identification of personal risks, behavior change theory, stages of 
change, goal-setting/action plan, decisional balance (pros and cons of behavior change). 
Discussions were largely driven by the interests of the participants.  Each group session except 
the beginning of the first session began and ended with personal goal setting/action plan and 
problem-solving to improve the participant’s risk profile. Peer input was solicited. 
 Patient satisfaction with the shared medical appointments as a method of care delivery 
was ascertained via a 5-point Likert scale at the end of the program via the simple question, 
“Overall, how satisfied are you with your experience with the shared medical appointments in 
which you participated?” Also assessed was a similar query about overall satisfaction with the 
traditional medical appointment to provide comparison (see Questionnaire, Appendix F). 
 Medical management.  Documentation in the patient’s electronic health record attests to 
individual medical evaluation and management components of care that were provided in the 
context of a shared medical appointment.  Treatment procedures with respect to medical 
management were in accordance with established national guidelines.  These included the 2014 
Evidence-Based Guideline for the Management of High Blood Pressure in Adults: Report from 
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The Panel Members Appointed to the Eighth Joint National Committee (JNC 8) (James et al., 
2014), the American Diabetes Association Standards of Medical Care in Diabetes – 2016 
(American Diabetes Association, 2016), and 2013 ACC/AHA Guideline on the Treatment of 
Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: a Report of the 
American College of Cardiology/American Heart Association Task Force on Practice Guidelines 
(Stone et al., 2014).  Individual assessment and medical management (as needed) took place 
privately.  Referrals were made, as indicated, such as to a dietician or to behavioral services.   
 The “ABCDE” approach developed at Johns Hopkins was used as a template for the 
medical management of the patient population (Blaha & Tota-Maharaj, 2012; Blaha, Bansal, 
Rouf, Golden, Blumenthal, & Defilippis, 2008; Tota-Maharaj, Defilippis, Blumenthal, & Blaha, 
2010).  The “ABCDE” approach informs management where “A” stands for individual patient 
assessment of cardiovascular risk. “A” also stands for aspirin therapy, when indicated, as an 
adjunct to inhibit platelet function and reduce thrombotic events (Blaha & Tota-Maharaj, 2012). 
“B” in the treatment algorithm includes blood pressure management/control.  “C” represents 
cholesterol and the importance of treating atherogenic dyslipidemia when indicated.  “C” may 
also stand for cigarettes, and should prompt counseling regarding cessation as a contributor to 
cardiovascular disease (National Center for Chronic Disease Prevention and Health Promotion, 
U. S. Office on Smoking and Health, 2014), even though cigarette smoking is not part of 
metabolic syndrome (Blaha & Tota-Maharaj, 2012).  “D” in the treatment algorithm includes 
diet and/or diabetes prevention and treatment.  “E” represents exercise.  Individual assessment 
and medical management (as needed) took place privately.  Blaha et al., 2008) describe this 
“ABCDE” approach to metabolic syndrome as a practical, step-wise framework for 
implementation of evidence-based treatment to reduce cardiovascular risk.  
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 Protected Health Information (PHI).  Participant/patient health information became part 
of the patient’s existing electronic health record (EHR) at Homer Medical Center.  PHI has 
implicit health information protections consistent with Privacy Practices that are a requirement of 
the Health Insurance Portability and Accountability Act (HIPAA) and which are upheld at 
Homer Medical Center/South Peninsula Hospital as outlined in the institution’s Notice of 
Privacy Practices.  
 Billing/coding.  Billing was done under the facilitating nurse practitioner’s name and was 
designated by fee structure consistent with appropriate current procedural terminology (CPT) 
codes for each participant visit.  The ICD-10 code for metabolic syndrome, E88.81, was not 
used.  Instead, more patient-specific codes were listed, such as I10 for essential (primary) 
hypertension and lipicentric codes that include E78.1 for elevated triglycerides and E78.6 for low 
HDL cholesterol, for example, as was indicated according to patient condition.   
Challenges to Project Implementation 
 Challenges to successful project implementation are considered to be part and parcel of 
project implementation.  A challenge with this project included recruitment and retention of 
participants to a program slated to take place during the traditionally very busy Alaskan summer 
months.  Several prospective patients declined after indicating early interest, leaving just seven 
participants.  Reasons that these patients cited for declining to participate included: “too busy”; 
previously-planned activities that prevented participation in the full six-week program; work 
schedule conflict with the shared medical appointment early evening meeting time; cost-
prohibitive nature of shared medical appointments due to lack of insurance or as yet unmet 
health insurance deductible. 
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 Facilitating patient engagement is a challenge.  So too is the challenge of facilitating 
lasting behavior change in the areas of weight loss, dietary practices and exercise (Olde, e 2013).  
Toward this end, the shared medical appointments included tenets of behavior change and 
participant support from session facilitators and peers alike. 
 Conducting the physical examination component of the shared medical appointment 
session for participants in a timely manner was a challenge.  Completing the physicals during the 
first part of the session is considered by Noffsinger (2009) to be the most productive and least 
disruptive to the group, yet was difficult for a single health care provider to accomplish so that 
the sessions begin on time, without undue wait by participants.  
Considerations That Prompted a Change in the Implementation Process   
 Awareness came mid-program about the Recent Update to the U.S. Cholesterol 
Treatment Guidelines (Nayor & Vasan, 2016), published May 3, 2016.  This article brought into 
question the validity of the JBS3 10-year cardiovascular risk calculator that was utilized for 
patients in the program and provided clarity regarding the use of an evidence-based 10-year 
cardiovascular risk tool.  The issue is of importance since thresholds for the use of a statin are 
predicated upon the recommendations in the risk calculator.  Consideration was given to use of 
an alternative to the JBS3 for this cohort of patients and to inform future clinical practice.  
Further discussion on this topic can be found in ensuing chapters.  
Conclusion 
This DNP project implementation process is informed by Donabedian.  It is the focus of 
chapter five and relates the processes of tailoring and implementing shared medical appointments 
for the cohort of seven patients with metabolic syndrome who participated in the program.  IRB 
project approval allowed activities related to this project to commence.  The six-week program of 
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shared medical appointments included education about metabolic syndrome informed by 
research and practice, facilitated group support, and medical management according to national 
guidelines as indicated by patient condition.  The shared medical appointments were led by a 
nurse practitioner and included a health care team of clinic and hospital health care personnel.  
Metrics and an end-program questionnaire provided patient information and perceptions about 
the program.  Challenges to project implementation and an alteration to the implementation 
process were identified.
 Outcomes and Evaluation   
 Donabedian’s framework elucidates the evidence-based practice change process that 
informed this project.  Donabedian (as cited in Holly, 2010) suggests an examination of three 
key measures – structure, process, and outcomes– that can be used in a clinical practice 
improvement project such as this one.  Structure and process were delineated in chapters four 
and five, respectively.  Outcomes are the products that result from the interaction of structure and 
process and reflect the effect on the patient and how well the intervention was done (Holly, 
2010).  Outcomes and evaluation are addressed in this chapter as they related to the institution of 
a program of shared medical appointments (SMA) for a small group of patients who met criteria 
for metabolic syndrome.  These shared medical appointments combined individual assessment 
and treatment by the project leader, with group education and facilitated peer interaction and 
peer support.  
Participant Demographics          
 The seven patients who participated in the program were representative of the larger adult 
clinic population according to ethnicity and race in that each self-described as non-Hispanic, 
White.  For each, their preferred language was English.  Six were female (mean age=58 years, 
range 37-67 years) and one was male, age 34.  The mean number of sessions attended by all 
participants was five; participation ranged from attendance in half of the scheduled shared 
medical appointments (n =2) to patient participation in all six weekly sessions (n =2).  All seven 
participants in the program had health insurance which included: Blue Cross Blue Shield 
(BCBS) of Alaska (n =5), Moda Health (n =1), and Medicare/BCBS/Aetna (n =1).   
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Program Inclusion 
 Patients all met diagnostic criteria for metabolic syndrome according to the Joint 
Scientific Statement of the International Diabetes Federation Task Force on Epidemiology and 
Prevention; National Heart, Lung, and Blood Institute: American Heart Association: World 
Heart Federation: International Atherosclerosis Society; and International Association for the 
Study of Obesity.  This definition specifies three of the following five criteria must be met: 
elevated waist circumference (population- and country-specific definitions but for these purposes 
defined as > 94 cm male, >80 cm female); elevated triglycerides greater than 150 mg/dL, or 
history of treatment for same; reduced HDL-C less than 40 mg/dL male or less than 50 mg/dL 
female, or history of treatment for reduced HDL-C; elevated blood pressure greater than 130/85 
mm Hg or treatment for previously diagnosed hypertension; and elevated fasting glucose greater 
than 100 mg/dL or drug treatment for elevated glucose (Alberti et al., 2009).  This definition 
excluded the parameters given for enlarged waist circumference as an obligatory criterion for 
diagnostic purposes.  The consensus definition includes enlarged waist circumference as one of 
the five criteria, with the presence of any three out of five sufficient for a diagnosis of metabolic 
syndrome (Alberti et al., 2009).  The seven participants met the diagnostic criteria for metabolic 
syndrome, including one with type 2 diabetes.  Most patients with type 2 diabetes will meet these 
diagnostic criteria for metabolic syndrome (Alberti et al., 2009).  One patient was recruited for 
the program based upon a history in which the patient met the International Diabetes Federation 
diagnostic criteria for metabolic syndrome that was originally used, but labs and assessment done 
at the start of the program placed the patient only at risk of metabolic syndrome.  In this case, the 
patient’s improvement in HDL-C found on lab testing –from HDL-C of 46 mg/dL19 months 
prior, to 55 mg/dL at the start of the program– negated the patient’s qualification for metabolic 
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syndrome according to International Diabetes Federation diagnostic criteria.  However, she did 
meet diagnostic criteria for metabolic syndrome according to the consensus definition of the 
Joint Scientific Statement of the International Diabetes Federation Task Force on Epidemiology 
and Prevention; National Heart, Lung, and Blood Institute: American Heart Association: World 
Heart Federation: International Atherosclerosis Society; and International Association for the 
Study of Obesit (Alberti et al., 2009).  To disallow participation seemingly based on such 
semantics would negate the patient’s elevated cardiovascular disease risk and preclude an 
intervention aimed at improving overall health.    
 One of the seven participants moved out of state at the conclusion of the shared medical 
appointments.  The participant was regarded as “lost to follow-up” since no data was obtained 
six weeks after the final session.  With no post-program biometric data for comparison, that 
participant’s data was excluded from analyses.  This left six participants for whom biometric 
data was obtained.  Individual qualifiers for participation in the program according to IDF 
criteria as well as the Joint Scientific Statement of the International Diabetes Federation Task 
Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute: American 
Heart Association: World Heart Federation: International Atherosclerosis Society; and 
International Association for the Study of Obesity (Alberti et al., 2009) are specified in Table 1. 
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Table 1
Individual Qualifiers According to Metabolic Syndrome Criteria 
 Patient 
 1 2 3 4 5 6 
 
Waist circumference>94 cm male, >80 cm female X X X X X X 
 
Triglycerides>150 mg/dL or history of treatment for same X X X X X X 
HDL-C<40 mg/dL male or <50 mg/dL female or history of treatment  
 
X X     
 
BP>130/85 mm Hg or treatment for previously diagnosed HTN  X X X X X 
 
FPG>100 mg/dL or previously diagnosed type 2 DM  X X    
 
Metrics  
 The following metrics relate to participant outcomes with respect to components of 
metabolic syndrome, arranged according to central adiposity, insulin resistance, atherogenic 
dyslipidemia, and elevated blood pressure.  Implicit as an underlying component of metabolic 
syndrome, exercise/inactivity is also described.  The clinical phenotype (central adiposity) and 
biological phenotype (insulin resistance, atherogenic dyslipidemia, elevated blood pressure) 
contribute to a proinflammatory state, with resultant vascular inflammation that can contribute to 
atherosclerosis (Kaur, 2014).  Measures of pro-inflammatory and prothrombotic state (e.g., hs-
CRP, apolipoprotein B (ApoB), etc.) (Isordia-Salas et al., 2014) were not assessed.  None of the 
patients had a personal history of tobacco use that contributed to cardiovascular disease risk.  
Tobacco use is not a part of metabolic syndrome (Blaha & Tota-Maharaj, 2012).  
 Central adiposity.  All participants demonstrated the requisite central obesity, as 
determined by enlarged waist circumference (>94 cm in men and >80 cm in women).  All 
participants were either overweight (n =2) or obese (n =4).  Throughout the course of the 
program no one participant changed from their pre-program BMI classification according to 
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obesity (BMI>30 kg/m2) or overweight (BMI >25.0-29.9 kg/m2).  Reduction in visceral fat is 
expected to bring about improvement in metabolic abnormalities, with hyperglycemia least 
sensitive to decrease in waist circumference, and lipid abnormalities most sensitive to such a 
decrease in waist circumference (Takahara & Shimomura, 2014).  
 Insulin resistance.  At the start of the program, only two of the four participants had 
fasting serum glucose assessed.  Only one of these two participants who had fasting serum 
glucose assessed at the start of the program met this criterion for metabolic syndrome (glucose 
113 mg/dL).  The other one of the two had a pre-program fasting glucose of 93 mg/dL, and thus 
did not meet this criterion for metabolic syndrome.  Irrespective of the value of pre-program 
serum glucose, the patient with a diagnosis of type 2 diabetes met this inclusion criterion.  Four 
of the six participants had random pre-and post-program serum glucose measures; thus, these 
measures could not be used as a criterion for metabolic syndrome diagnosis according to the 
Joint Scientific Statement of the International Diabetes Federation Task Force on Epidemiology 
and Prevention; National Heart, Lung, and Blood Institute: American Heart Association: World 
Heart Federation: International Atherosclerosis Society; and International Association for the 
Study of Obesity.  The American Diabetes Association considers fasting plasma glucose 
erroneous in describing chronic medical conditions (Bonora & Tuomilehto, 2011).  Because, 
inherent in the measurement of hemoglobin A1c is the repeated assessment of fasting glucose 
levels, hypoglycemia, and postprandial peaks, hemoglobin A1c is a more robust measure, and 
therefore more reliable and representative of average glucose than fasting plasma glucose 
(Bonora & Tuomilehto, 2011).  All participants had pre-and post-program hemoglobin A1c 
measurements assessed.  One patient was determined to have pre-diabetes, evidenced by a 
hemoglobin A1c equal to 5.9% (pre-diabetes 5.7-6.4%).  
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 Atherogenic dyslipidemia.  Originally assessed using the third iteration of the JBS3 
calculator, 10-year cardiovascular risk was later reassessed pre- and post-program based upon 
the American College of Cardiology/American Heart Association (ACC/AHA) pooled cohort 
10-year cardiovascular risk equation because the latter was found to be externally validated 
(Munter et al., 2014; Wilson, 2016) whereas the JBS3 was not.  The JBS3 risk tool had been 
used as was the custom of primary care providers in the clinic.  JBS3 has the advantage of 
modifying future risk calculations based on a modification of lifestyle factors such as smoking 
cessation (Wilson, 2016), and acts as a helpful educational tool in that respect.  Another benefit 
of the JBS3 risk tool is its estimation of “heart age”, as well as risk beyond the 10-year risk 
estimate to provide” lifetime risk” (Wilson, 2016).  However, data that inform the JBS3 are from 
statistical models and have not been externally validated (Wilson, 2016).  The National Heart, 
Lung, and Blood Institute (NHLBI) assessed the body of evidence related to cardiovascular risk 
reduction in their evidence report, Assessing Cardiovascular Risk: Systematic Evidence Review 
from the Risk Assessment Work Group, 2013 (U.S. Department of Health and Human Services, 
2013).  
 As with glucose, lipid testing varied for each patient according to pre-and post-program 
fasting or non-fasting random evaluation: Four patients’ lipids were assessed in a random state 
pre- and post-program; one patient had assessment of lipids in a fasting state pre- and post-
program, and; one patient had pre-program assessment of lipids in a random state, whereas post-
program assessment of lipids had been done in a fasting state.  Lack of contiguity in pre- and 
post-program lipid testing may limit findings.  Although fasting lipid values have been the 
conventional testing method, fasting and non-fasting random lipid values vary over time and are 
comparable in their prediction of cardiovascular disease risk (Nordestgaard et al., 2016).  In their 
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joint consensus statement from the European Atherosclerosis Society and European Federation 
of Clinical Chemistry and Laboratory Medicine, Nordestgaard et al. (2016) compared fasting and 
non-fasting random lipid profiles and found that the mean changes one to six hours 
postprandially are not clinically significant (+26 mg/dl for triglycerides, -8 mg/dL for total 
cholesterol, -8 mg/dL for LDL-C, -8 mg/dL for calculated non-HDL-C).  Using this correction, 
the fasting and non-fasting lipid values can be considered complimentary but not mutually 
exclusive (Nordestgaard et al., 2016).  Nordestgaard et al. (2016) recommended the following be 
considered abnormal when non-fasting serum samples are obtained: triglycerides≥175 mg/dL, 
total cholesterol≥190 mg/dL, LDL-C≥115 mg/dL), and calculated non-HDL cholesterol ≥150 
mg/dL.  HDL-C is not influenced by fasting/non-fasting status.  
 Notwithstanding limitations related to the pre- and post-program contiguity of fasting 
versus non-fasting random state of lipid testing, five patients were shown to have had ACC/AHA 
10-year risk under the 7.5% cutoff that suggests insufficient cardiovascular disease risk to 
warrant pharmacologic treatment with a statin.  One patient’s risk exceeded this threshold, with 
ACC/AHA 10-year cardiovascular risk determined to be 13.2 and 13.7 pre- and post-program, 
respectively.  In this patient, whereas the 2013 ACC/AHA guidelines do not require fasting lipids 
to determine criteria for statin initiation to calculate LDL cholesterol (LDL-C), the 
recommendation for fasting lipids is in place when non-HDL-C>220 mg/dL or triglycerides>500 
mg/dL since these may indicate genetic propensity for hypertriglyceridemia (Nordestgaard et al., 
2016).  The patient with type 2 diabetes had been prescribed appropriate statin therapy and was 
medically managed in accordance with the American Diabetes Association Standards of Medical 
Care in Diabetes – 2016. 
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 Elevated blood pressure.  At the program start, two patients had systolic blood pressure 
measures above 140 mm Hg (both 146 mm Hg), with one of the two also demonstrating diastolic 
pressure indicative of hypertension (90 mm Hg).  Neither of these patients with elevated blood 
pressure carried a previous diagnosis of hypertension, and they were normotensive at program 
end although their systolic pressures remained in the at-risk range above 130 mm Hg.  Medically 
managed with an angiotensin-converting enzyme (ACE) inhibitor, the participant with type 2 
diabetes also was normotensive.  At program end, four participants remained with systolic blood 
pressure in the 130s and so were without significant risk reduction, in keeping with this criterion 
for metabolic syndrome.  Elevated blood pressure is an important risk factor for cardiovascular 
disease.  Inferences that may be made about the shared medical appointments’ influence on 
blood pressure are limited due to noticeable alterations in blood pressure variability that are 
demonstrated over the short and long term and which can be attributed to behavioral, emotional, 
postural, and other influences (Grassi et al., 2012).  
 Inactivity.  Exercise was documented in the electronic health record as a “vital sign” in 
accordance with ACSM Exercise is Medicine tenets.  Patient participation in moderate aerobic 
exercise, measured throughout the program according to patient report in minutes per day and 
days per week, improved significantly for five participants.  For one participant exercise gains 
were not sustained so that the patient had resumed a sedentary lifestyle six weeks following the 
last shared medical appointment.  Post-program, only two of the six participants met the ACSM 
minimum recommended 150 minutes of exercise per week.  Association of total minutes of 
exercise pre- and post-program and correlation with improvement in health measures seems an 
inherent teaching tool for participants in the program, as participant’s time commitment to 
exercise is expected to result in measurable health benefits.  
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Statistical Analysis  
 SPSS Statistics software was used to perform the Wilcoxon signed rank test, also known 
as the Wilcoxon matched pairs ranks test, on data elements pre- and post-program.  The 
nonparametric equivalent to the paired t-test, the Wilcoxon signed rank test, is appropriate since 
comparison was made on a nominal sample size where the distribution between the pairs were 
non-normally distributed (McDonald, 2014).  The significance of the results is reported as a p -
value with the conventional statistically significant values below 0.05 (Tallant, 2010).  
Statistically significant values, then, are highlighted in rows and designated with an asterisk (*) 
in Table 2:  
 
Table 2 
Summary of Intercorrelations Pre- and Post-Program using Wilcoxon Signed Rank Test 
 Z value p value 
Weight (kg) -1.153 .249 
BMI (kg/m2) -1.363 .173 
Waist circumference (cm) -0.948 .343 
Systolic blood pressure (mm Hg) -0.271 .786 
Diastolic blood pressure (mm Hg) -1.786 .074 
Hemoglobin A1C (%) -1.473 .141 
Total cholesterol (mg/dL) -2.201  .028* 
Triglycerides (mg/dL) -2.201  .028* 
HDL-C (mg/dL) -0.674 .500 
LDL-C (mg/dL) -0.524 .600 
non HDL-C -2.201  .028* 
Self-reported exercise (minutes per week) -2.032  .042* 
10-year cardiovascular risk (%) -0.816 .414 
    
 *denotes statistical significance at .050  
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 The Wilcoxon signed rank test demonstrated a statistically significant increase in total 
cholesterol, triglycerides, non-HDL-C, and in minutes of exercise post-program compared to the 
measures at the start of the program.  Clearly, only the last is a desired result of the intervention.  
Statistically insignificant change in pre- and post-program values included those for weight/BMI, 
waist circumference, systolic and diastolic blood pressure, HDL-C, LDL-C, and ACC/AHA 10-
year cardiovascular disease risk.  With respect to lipids and the resultant calculated 10-year 
cardiovascular disease risk score, these findings may be limited by the incongruity of pre- and 
post-program fasting and non-fasting measures.  
Post-Program Questionnaire 
 Three participants completed the post-program questionnaire (see Questionnaire, 
Appendix F).  Patient satisfaction with the shared medical appointments as a method of care 
delivery was ascertained via a 5-point Likert scale (1-very unsatisfied, 2-unsatisfied, 3-neutral, 4-
satisfied, 5-very satisfied) at the end of the program via the simple question: “Overall, how 
satisfied are you with your experience with the shared medical appointments in which you 
participated?”  Also assessed was a similar query about overall satisfaction with the traditional 
medical appointment, to provide a comparison.  Of the three surveys that were returned, two 
participants rated being “very satisfied” with care delivery in these shared medical appointments 
compared to “neutral” with care in a standard appointment, and one participant rated being 
similarly “satisfied” with both shared medical appointments and standard medical appointments.  
 Participants were asked to respond in written form to the questions, “Did you experience 
anything you didn’t like?   Are there any drawbacks to shared medical appointments?” 
Comments were as follows:  
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 “I got bored hearing everyone’s excuses until I realized that I had been doing the same 
thing.  Now that’s a real wake up call.” 
 “Quiet people don’t talk as much.  More talkative people can monopolize the group.” 
Asked “what did you gain from participating in the program?  What worked?  (consider benefits 
from group participation, what you learned that was helpful, presentations by other health 
professionals, how shared medical appointments may have motivated you to take better care of 
yourself)”, participants responded: 
 “It was helpful to feel accountable for my behavior and discuss and validate with others.  
Learned more about metabolic syndrome, setting personal goals, nutrition tips, action planning.  
Thank you.” 
 “New knowledge.  Lots of new information on blood sugars, how body works with blood 
sugars, refreshers on meal/food size.  The appointments helped motivate me to get moving and a 
reminder that it’s not just me, we can help each other.  I really liked that other people were 
brought in to help with questions and giving out more ideas.”   
 “There really wasn’t much that I didn’t already know.  If your [sic] overweight or have 
metabolic syndrome, believe me, you know what your [sic] supposed to do!   I did enjoy the info. 
and reiteration of information to motivate me.  As far as having shared appointments, don’t think 
that they are that beneficial.  I guess I don’t play well with others.  I felt we got off base on why 
we were there at times.” 
Additional written comments included: 
 “Thanks for including me.  Can’t stop learning – eat less, move more!  Can’t get any 
simpler.”  
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An unsolicited verbal comment was made by one participant after the class which reflected her 
personal view related to weight loss:  
 “It’s not good to lose too much weight because when you get old you get all saggy-
looking.” 
Medical Management  
 Documentation in the patient’s electronic health record attests to individual medical 
evaluation and management components of care that were provided in the context of a shared 
medical appointment.  Treatment procedures with respect to medical management were in 
accordance with established national guidelines.  These included the 2014 Evidence-Based 
Guideline for the Management of High Blood Pressure in Adults: Report from The Panel 
Members Appointed to the Eighth Joint National Committee (JNC 8) (James et al., 2014), the 
American Diabetes Association Standards of Medical Care in Diabetes – 2016 (American 
Diabetes Association, 2016), and 2013 ACC/AHA Guideline on the Treatment of Blood 
Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: a Report of the American 
College of Cardiology/American Heart Association Task Force on Practice Guidelines (Stone et 
al., 2014).  The patient with type 2 diabetes was receiving optimal medical management of risks 
by current ADA guidelines.  Overall, all patients were found to be at elevated cardiovascular risk 
pre-program, and they remained at risk post-program according to standard assessment 
parameters.   
 Referrals were made, as indicated, for two patients, one to a dietician, and one to 
behavioral services for concomitant depression.  There were no disputed claims with any health 
insurance submission.  Over the course of six weeks, patients in the program sought care 
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unrelated to metabolic syndrome, such as for an acute upper respiratory infection (n =1), annual 
exam (n =1), and pre-existing musculoskeletal condition (n =1).    
Project Limitations 
Project limitations include the nominal group size, the incongruity of pre- and post-
program fasting and non-fasting lipid results, and relatively short duration of the program.  Self-
selection bias may be at play, as those willing to participate may manifest higher relative 
readiness for behavior change than the general population.  There exist many confounding 
variables.  As such, results are not generalizable to a larger population.   
Conclusion 
Outcomes related to implementation of the clinical practice improvement project are 
informed by Donabedian and outlined in chapter six.  The program participants were defined 
according to demographics and metrics that relate to metabolic syndrome and inherent 
cardiovascular disease risks that include central adiposity, glucose intolerance, atherogenic 
dyslipidemia, elevated blood pressure, and exercise pattern.  A Wilcoxon signed rank test 
revealed statistically significant increase in total cholesterol, triglycerides, non-HDL-C and self-
reported minutes of exercise per week post-program compared to the measures at the start of the 
program of shared medical appointments (see Table 2).  The Wilcoxon signed ranks test 
demonstrated no statistically significant improvement in weight/BMI, waist circumference, 
systolic and diastolic blood pressure, HDL-C, LDL-C, or 10-year cardiovascular disease risk.  
Limitations due to inconsistency in measuring pre- and post-program lipids with respect to 
fasting or non-fasting random values are recognized.  Post-program feedback via completion of a 
questionnaire was received by three participants.  Two participants rated being “very satisfied” 
with care delivery in these shared medical appointments compared to a rating of “neutral” with 
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care in a standard appointment, and one participant rated being similarly “satisfied” with both 
shared medical appointments and standard medical appointments.  Patients remained at elevated 
cardiovascular disease risk post-program according to standard assessment parameters.
 Implications for Nursing Practice 
	 Chapter seven has as its focus a description of the Essentials of Doctoral Education for 
Advanced Nursing Practice (American Association of Colleges of Nursing (AACN), 2006) as 
they relate to this Doctor of Nursing Practice (DNP) project.  This DNP project –implementation 
of a clinical practice improvement project focused on using shared metabolic appointments to 
address cardiovascular risk in patients with metabolic syndrome– meets all eight DNP Essentials.  
A synthesis of these competencies is outlined herein. 
DNP Essential I.  Scientific Underpinnings for Practice 
 DNP Essential I recognizes foundational nursing tenets, including scientific 
underpinnings that inform DNP practice.  In this project is reflected evidence that speaks to the 
need for intervention in patients that meet diagnostic criteria for metabolic syndrome because of 
their increased cardiovascular disease risk and the data that supports the importance of these 
interventions.  Nursing science supports the development of theories and models to guide nursing 
practice (AACN, 2006).  In this project, Donabedian’s framework was utilized to expand further 
on steps in the Model for Evidence-Based Practice Change.  Shared medical appointments were 
utilized as a care delivery method in accordance with the Institute of Medicine’s aim to use 
evidence from research “to determine effective strategies for implementing system-based change 
to improve care processes and patient outcomes” (Institute of Medicine, 2011, as cited in Melnyk 
& Fineout-Overholt, 2015, p. 77).  This program included evidence-based guidelines for 
screening, evaluation, and medical management.  In keeping with scientific underpinnings for 
practice is the recognition that additional research is needed to better understand what elements 
improve outcomes, what Kirsh et al. (2007) describe as the “physiology” of shared medical 
appointments that account for the clinical improvement that is evidenced in the literature. 
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 Inherent in this project are other foundational nursing tenets outlined in DNP Essential I. 
These include “the patterning of human behavior in interaction with the environment”, “the 
wholeness or health of human beings recognizing that they are in continuous interaction with 
their environments”, and “the nursing actions or processes by which positive changes in health 
status are affected” (AACN, 2006, p. 9).  These tenets must be considered – and accommodated 
–as they are so very relevant where lifestyle choices and behavior change impact individual 
health and the health of populations, and as they affect program outcomes.  
DNP Essential II.  Organizational and Systems Leadership for Quality Improvement and 
Systems Thinking 
 DNP Essential II expounds on the leadership that is necessary to improve health care at 
the organizational and systems level.  It embraces the role of the DNP in the delivery of care in 
order to improve health care.  Leadership for systems level change involved system redesign 
from that of traditional office visits to one of shared medical appointments. At the same time, 
attention remained focused on the direct care of the individual within the context of a focus on 
the needs of a cohort of patients (AACN, 2006).  Recognizing that “improvements in practice are 
neither sustainable nor measurable without corresponding changes in organizational 
arrangements…” (AACN, 2006, p. 10), further changes will need to be made in the 
organizational structure as well as professional culture to accommodate additional numbers of 
patients in this model of care.  Such a shift assumes engaged leadership. 
DNP Essential III.  Clinical Scholarship and Analytical Methods for Evidence-Based 
Practice 
 Scientific research and principles are the foundations upon which DNP Essential III 
recognizes a translation of research into practice, evaluation of practice, and practice 
improvement in an effort to improve care (St. John Fisher College, n.d.).  In this project, it 
included discernment in choice of a 10-year cardiovascular risk calculator as an assessment tool 
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and patient teaching tool, a decision which involved a transition from a tool that was used by 
convention to one that is targeted to the population and externally validated.  It included 
discernment in choice of evidence-based clinical practice guidelines.  It included incorporation 
of self-reported minutes per week of exercise as a “vital sign” in the electronic health record 
(EHR).  It also included incorporation of the expertise of Noffsinger (2009) with respect to 
program design and organizational aspects of conducting physical shared medical appointments. 
This included evidence supporting the recommended frequency of shared medical appointments 
and the personal invitation extended to participants by a primary care provider, which was 
suggested by Donabedian as the single most effective means of getting patients to attend shared 
medical appointments, etc.  DNP Essential III, according to Boyer (1990, p. 21, as cited in 
AACN, 2006) reflects more than discovery of new knowledge but rather a paradigm in which: 
“the scholarship of discovery and integration ‘reflects the investigative and synthesizing 
traditions of academic life’; scholars give meaning to isolated facts and make connections across 
disciplines through the scholarship of integration; and the scholar applies knowledge to solve a 
problem via the scholarship of application (referred to as the scholarship of practice in nursing).”  
DNP Essential IV.  Information Systems/Technology and Patient Care Technology for the 
Improvement and Transformation of Health Care  
DNP Essential IV recognizes the management, evaluation, and utilization of information 
technology to improve health outcomes (St. John Fisher College, n.d.).  Reliance was placed on 
informatics in this project: through a literature search of databases in the UAA Consortium 
Library, data analysis using SPSS software to determine statistical significance of outcomes data, 
documentation of clinically-relevant patient information in the EHR, and incorporation of the 
validated exercise as “vital sign” in the EHR.  Templates were created in the EHR to facilitate 
documentation at each visit.  PPRNet (Primary (Care) Practices Research Network), approved by 
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the Centers for Medicare and Medicaid Services (CMS) as a Qualified Clinical Data Registry 
(QCDR) contains clinical data registry information that allowed data to be mined from the EHR 
and enabled a search for patients according to certain metrics like systolic blood pressure or body 
mass index, and so define a population of patients according to diagnostic criteria for metabolic 
syndrome.  
DNP Essential V.  Health Care Policy for Advocacy in Health Care  
 DNP Essential V recognizes an accountability of DNP-prepared nurses to influence 
policy in a way that improves the health of individuals and populations. This project acted in 
accordance with health care policy, rather than setting health care policy.  The project 
implementation occurred at the institution level but has a much broader scope.  Knowledge of 
project scope may yet inform health policy at local, state, regional, federal, and international 
levels, with regard to health care finance, regulation, and care delivery, etc. 
 Implementation of shared medical appointments to affect cardiovascular disease risk in 
patients with metabolic syndrome aligns with the National Quality Strategy (NQS).  The NQS, 
mandated by the Patient Protection and Affordable Care Act, includes three overarching aims 
that build on the Institute for Healthcare Improvement’s Triple Aim (Agency for Healthcare 
Research and Quality (AHRQ), 2015).  With respect to the first two aims that include better care 
and healthy people, this DNP project supports these aims in its focus on patient-centered care, 
and in the provision of evidence-based interventions address behavioral, social, and 
environmental determinants of health, respectively (AHRQ, 2015).  While a formal cost-benefit 
analysis was not conducted in this DNP project, shared medical appointments have been shown 
to support the third aim that is cost-effective care (Noffsinger, 2009).  Shared medical 
appointments as a care delivery method advance priorities that are part of the National Quality 
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Strategy.  Some of these strategies include: patient as a partner in care, promotion of effective 
prevention and treatment practices related to cardiovascular disease, and promoting best 
practices to facilitate healthy living (AHRQ, 2015).  
DNP Essential VI.  Interprofessional Collaboration for Improving Patient and Population 
Health Outcomes   
 DNP Essential VII recognizes that translation of evidence into practice through 
leadership requires community-building, that which Brown and Kaplan (2016) refer to as 
building bonds and collegial connections.  Such a culture of connections is necessary for 
project implementation and improved health care, for professional development, and as a 
condition for furthering the nursing profession.  The project necessitated inter- and intra-
professional collaboration to reorganize the standard care structure from the traditional 
office visit to shared medical appointments so improvements in practice might be 
realized.   
DNP Essential VII.  Clinical Prevention and Population Health for Improving the Nation’s 
Health  
 DNP Essential VII identifies with the nursing focus on health promotion and disease 
prevention in the context of improving healthcare at all levels.  Shared medical appointments 
focused on individual assessment, education, and disease management within the context of the 
aggregate that was the larger population with metabolic syndrome.  Individuals benefited from 
counseling and support from the interchange within the group.  Implementation of the shared 
medical appointments for patients with metabolic syndrome addresses several Healthy People 
2020 goals and objectives.  These include the Clinical Preventive Services leading health 
indicators for adults with hypertension whose blood pressure is under control, and those with 
suboptimal glycemic control; and nutrition, physical activity, and obesity leading health 
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indicators that include adults meeting aerobic and strength training objectives, and efforts 
targeting adult obesity (Office of Disease Prevention and Health Promotion, 2016).  
DNP Essential VIII.  Advanced Nursing Practice 
 DNP Essential VIII recognizes the value of the highest level of nursing practice.  This 
DNP project supported a level of specialization and depth of knowledge within the breadth of 
family practice nursing. 
Implications   
 Notwithstanding the project’s limitations, previously mentioned, the project demonstrates 
the feasibility of the use of shared medical appointments to address cardiovascular disease risk in 
patients with metabolic syndrome.  This mode of health care delivery can be implemented for 
health promotion and disease management in other patient populations.  The project 
demonstrates the translation of evidence-based research into practice and an understanding of the 
process by which this may take place.  As such, the DNP process itself has profound implications 
as it informs future projects.  The project allowed a deeper understanding of the state of the 
science related to the components or the whole of the metabolic syndrome as they apply to 
clinical practice.  Certainly, improved provider awareness and recognition facilitates 
intervention.  The project allowed a certain depth of knowledge within the wide breadth of the 
topic, and within the breadth that advance practice nursing encompasses in the field of family 
practice.   
Conclusion 
Chapter	seven	includes	a	synthesis	of	the	Essentials	of	Doctoral	Education	for	
Advanced	Nursing	Practice	as	they	relate	to	the	DNP	project.		These eight DNP Essentials are 
considered by the AACN to be foundational outcome competencies for the DNP-prepared 
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advanced practice registered nurse.  Implementation of the clinical practice improvement project 
is in accordance with aims the National Quality Strategy. 
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Summary and Conclusion 
The application of evidence-based knowledge to clinical practice is necessary in order to 
further nursing science and to ensure better, more affordable care for patients and populations.  
The process of improving practice through application of research is at the heart of the Doctor of 
Nursing Practice (DNP) project.  Foundational to the DNP project are the Essentials of Doctoral 
Education for Advanced Nursing Practice as they inform goals that align with the National 
Quality Strategy.  
DNP Project Process 
To move evidence-based knowledge into practice, strategies such as the one employed in 
the DNP project are needed.  Rosswurm and Larrabee’s model for evidence-based practice and 
Donabedian’s framework were chosen to guide the intervention of using shared medical 
appointments to improve cardiovascular risk in patients with metabolic syndrome.  Physicals 
shared medical appointments were carried out weekly over the course of six weeks and involved 
individual care including assessment and medical management in short, private sessions, and 
facilitated group counseling and support.  Informational topics were facilitated by the advance 
practice registered nurse and nutrition services staff, as well as by a guest lecture on mindful 
eating by a psychiatric nurse practitioner.  The educational curricula were consistent with that of 
the TRIMS study.  Statistically significant improvement was noted only in the measure of self-
reported exercise duration.  Post-program, patients remained at elevated cardiovascular disease 
risk that is a condition of metabolic syndrome.  Patients reported satisfaction with shared medical 
appointments equal to or greater than their satisfaction with traditional office visits.  
 The American Association of Colleges of Nursing included Boyer’s vision of scholarship 
for the DNP program.  Boyer refocused attention on the scholarship of teaching and service in 
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nursing, with less attention to the established traditions of research and publication (White & 
Zaccagnini, 2015).  Boyer’s (1996) reimagination of scholarship included four parts: a) the 
scholarship of discovery, b) the scholarship of integration, c) the scholarship of teaching, and d) 
the scholarship of application informs the DNP project process (Boyer, 1996).  This DNP project 
process encompasses Boyer’s four criteria, with emphasis on the scholarship of integration and 
the scholarship of application.   
Reflection 
 DNP-prepared leaders are needed as change agents to tackle the complex challenges in 
our current health care system.  The overarching challenge in today’s health care environment is 
how to fulfill the expectations of a profession when those expectations are to bring something 
new to practice in order to improve the patient experience of care, improve	population	health,	
and	reduce per	capita	costs	of	health	care	that	are	the	aims	of	the	Institute for Healthcare 
Improvement (IHI) Triple Aim Initiative (Berwick, Nolan, & Whittington, 2008; Institute for 
Healthcare Improvement, 2016).  For a DNP-prepared advanced practice registered nurse, 
success may be measured by how he/she shall “think strategically, innovate, and engage 
stakeholders in meaningful system improvement” (Kendall-Gallagher & Breslin, 2013, p. 259).  
This DNP project was a very small manifestation of such strategic vision.  The DNP project 
process outlines requisite knowledge and processes to affect change.  
Conclusion 
 Goethe (as cited in White & Zaccagnini, 2015, p 451) is quoted as saying “Knowing is 
not enough; we must apply.  Willing is not enough; we must do”.  The quote seems relevant as it 
applies to the DNP project intent and scope.  This project reflects that translation of evidence-
based knowledge into a project in accordance with aims that are consistent with improving 
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practice, processes, and/or outcomes (White & Zaccagnini, 2015).  Its foundational tenet is the 
impact the process has on improving practice and reducing disease burden.  This project, guided 
by the Model for Evidence-based Change, reflects that translation of evidence-based knowledge 
into a project whose aims are consistent with the overarching goals of the National Quality 
Strategy.  The process that included research, design, implementation, and evaluation availed 
itself to a process guided by the Model for Evidence-Based Practice Change.  It is a model that 
lends itself to future clinical practice improvement efforts. 
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